CGEM
Price
$8.21
Change
+$0.06 (+0.74%)
Updated
Mar 11, 01:53 PM (EDT)
Capitalization
509.65M
70 days until earnings call
MDGL
Price
$316.06
Change
-$13.10 (-3.98%)
Updated
Mar 11, 01:57 PM (EDT)
Capitalization
7.27B
63 days until earnings call
Ad is loading...

CGEM vs MDGL

Header iconCGEM vs MDGL Comparison
Open Charts CGEM vs MDGLBanner chart's image
Cullinan Therapeutics
Price$8.21
Change+$0.06 (+0.74%)
Volume$100
Capitalization509.65M
Madrigal Pharmaceuticals
Price$316.06
Change-$13.10 (-3.98%)
Volume$1.21K
Capitalization7.27B
CGEM vs MDGL Comparison Chart
Loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEM vs. MDGL commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a StrongBuy and MDGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (CGEM: $8.15 vs. MDGL: $329.16)
Brand notoriety: CGEM and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 129% vs. MDGL: 62%
Market capitalization -- CGEM: $509.65M vs. MDGL: $7.27B
CGEM [@Biotechnology] is valued at $509.65M. MDGL’s [@Biotechnology] market capitalization is $7.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileMDGL’s FA Score has 1 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • MDGL’s FA Score: 1 green, 4 red.
According to our system of comparison, CGEM is a better buy in the long-term than MDGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 4 TA indicator(s) are bullish while MDGL’s TA Score has 6 bullish TA indicator(s).

  • CGEM’s TA Score: 4 bullish, 3 bearish.
  • MDGL’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than CGEM.

Price Growth

CGEM (@Biotechnology) experienced а +1.87% price change this week, while MDGL (@Biotechnology) price change was +5.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.73%. For the same industry, the average monthly price growth was -9.34%, and the average quarterly price growth was -8.76%.

Reported Earning Dates

CGEM is expected to report earnings on May 20, 2025.

MDGL is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-0.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($7.27B) has a higher market cap than CGEM($510M). MDGL YTD gains are higher at: 6.673 vs. CGEM (-33.087). CGEM has higher annual earnings (EBITDA): -187.05M vs. MDGL (-502.65M). MDGL has more cash in the bank: 999M vs. CGEM (578M). CGEM has less debt than MDGL: CGEM (2.45M) vs MDGL (119M). MDGL has higher revenues than CGEM: MDGL (76.8M) vs CGEM (0).
CGEMMDGLCGEM / MDGL
Capitalization510M7.27B7%
EBITDA-187.05M-502.65M37%
Gain YTD-33.0876.673-496%
P/E RatioN/AN/A-
Revenue076.8M-
Total Cash578M999M58%
Total Debt2.45M119M2%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
24
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGEMMDGL
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 15 days ago
81%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
67%
View a ticker or compare two or three
Ad is loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OVEIX14.89N/A
N/A
Sterling Capital Mid Value I
CSDIX17.93N/A
N/A
Cohen & Steers Real Estate Securities I
MBVKX19.49N/A
N/A
BlackRock Large Cap Focus Value K
QBDAX8.25N/A
N/A
Quantified Managed Income Advisor
VSRDX17.17N/A
N/A
VALIC Company I U.S. Socially Rspnb

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with MDGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-6.43%
MDGL - CGEM
50%
Loosely correlated
-0.68%
GOSS - CGEM
45%
Loosely correlated
-4.96%
ORMP - CGEM
42%
Loosely correlated
-1.95%
ABOS - CGEM
36%
Loosely correlated
-4.00%
IDYA - CGEM
36%
Loosely correlated
-4.98%
More